Preliminary research show conolidine might inhibit distinct ion channels, lessening neuronal excitability and limiting suffering indicators. This mechanism is particularly appropriate in neuropathic discomfort, wherever abnormal signaling brings about persistent discomfort. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR)